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Members of the basic helix–loop–helix (bHLH) transcription factor family play an essential role in multiple developmental
processes. During neurogenesis, positive and negative regulation by bHLH proteins is essential for proper development. Here
we report the identification and initial characterization of the bHLH gene, Neuronal twist (N-twist), named for its neural
expression pattern and high sequence homology and physical linkage to the mesodermal inhibitor, M-twist. N-twist is
expressed in the developing mouse central nervous system in the midbrain, hindbrain, and neural tube. This neural
expression is conserved in invertebrates, as expression of the Drosophila ortholog of N-twist is also restricted to the central
nervous system. Like other bHLH family members, N-Twist heterodimerizes with E protein and binds DNA at a consensus
bHLH-binding site, the E box. We show that N-Twist inhibits MASH1-dependent transcriptional activation by sequestering
E protein in a dominant negative fashion. Thus, these studies support the notion that N-Twist represents a novel negative
regulator of neurogenesis. © 2002 Elsevier Science (USA)
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Members of the basic helix–loop–helix (bHLH) family of
transcription factors are involved in multiple developmen-
tal programs, including myogenesis, hematopoiesis, and
neurogenesis (reviewed in Olson and Klein, 1994; Lee, 1997;
Guillemot, 1995, 1999; Staal et al., 2001). Many tissue-
specific bHLH proteins dimerize via their HLH domain
with ubiquitously expressed bHLH proteins of the E2A
family. The basic domains of these heterodimers mediate
DNA binding at a consensus sequence (CANNTG) known
as an E box. E boxes are found in the regulatory elements of
many important developmentally regulated genes and are
often required for gene activation. A wide variety of char-
acterized bHLH transcription factors function as activators.
1 These authors contributed equally to this work.
2 To whom correspondence should be addressed. Fax: (415) 514-174In both myogenesis and neurogenesis, several bHLH acti-
vators are responsible for specifying cells to a tissue-specific
fate, and then for initiating the differentiation program. For
example, bHLH proteins of the achaete-scute family, such
as MASH1, activate gene expression during neurogenesis.
In mice lacking MASH1, entire populations of neural pre-
cursors are absent (Guillemot et al., 1993; Cau et al., 1997;
Casarosa et al., 1999). Other bHLH proteins function as
inhibitors rather than activators of transcription. Members
of the Hairy-Enhancer of Split (HES) family represent ex-
amples of bHLH transcriptional inhibitors that function as
negative regulators of neural specification and differentia-
tion (Kageyama et al., 1997). Cells mis-expressing HES
proteins exhibit a delay in terminal differentiation and
instead continue to divide (Kageyama et al., 1997). The
absence of HES proteins results in premature differentia-
tion, as seen in the developing retina (Tomita et al., 1996),
or in the overproduction of neural precursors, as seen in the
olfactory epithelium (Cau et al., 2000). These examples2550. E-mail: bblack@itsa.ucsf.edu.0012-1606/02 $35.00
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demonstrate the importance of balancing positive and nega-
tive regulation during neurogenesis. It is generally accepted
that the neurogenic program begins with specification of
preneural cells followed by neuronal differentiation. How-
ever, how the timing of this process is established and how
neural subtypes are specified are two of many questions
that remain to be answered more fully to gain a better
understanding of neural development. It is likely that
bHLH family members, with their abundant expression and
recurring roles in developmental programs, are involved in
these processes.
Here we report the identification of a novel bHLH gene,
N-twist. N-twist is expressed in the developing central
nervous system (CNS). N-twist shows high sequence simi-
larity to the mesodermal inhibitor M-twist, and these genes
are linked on human chromosome 7p15. N-twist sequence
and expression in the developing CNS are conserved be-
tween vertebrates and invertebrates. In this study, we show
that N-twist dimerizes with E proteins and this het-
erodimer binds efficiently to a consensus E box. N-Twist
functions as a transcriptional inhibitor of the neurogenic
transcription factor MASH1 by dimerizing with E protein in
a dominant negative fashion. Thus, we propose that
N-Twist is a novel negative regulator of neurogenesis.
MATERIALS AND METHODS
Identification and Cloning of N-twist
Hypothetical bHLH sequences were created based upon con-
served motifs in the bHLH domains of known mesodermal and
neural bHLH factors. These sequences were then used in the
BLAST algorithm to identify novel bHLH sequences in the human
genome. N-Twist was one of five novel bHLH proteins identified
using this approach. PCR primers (5-ACCAGCAACCTCGC-
CCCTCCC-3 and 5-CCCTTTAGCCTCACCCAGTGC-3) were
used to amplify the N-twist region from human genomic DNA, and
the resulting product was cloned and sequenced. To identify the
mouse ortholog of N-twist, PCR primers were constructed based
upon the human sequence, and these were used to amplify the
bHLH region in mouse. The resulting mouse PCR product was then
used to screen mouse genomic and cDNA libraries, and the mouse
gene was cloned by using standard techniques. A search of the
Drosophila expressed sequence tag (EST) database identified a part
of the fly N-twist ortholog (GenBank Accession No. F54684) called
CG6913. The GenBank Accession Nos. for mouse, human, and
Drosophila N-twist are AF51721, AF51722, and AF517123, respec-
tively. The predicted amino acid sequence of the Takifugu rubripes
N-Twist bHLH domain was determined by analyzing putative open
reading frames in genomic scaffold FS:S000130 from the pufferfish
genome project Web site (http://fugu.hgmp.mrc.ac.uk).
RT-PCR
Wild-type mouse embryos were collected at 7.5, 8.5, 9.5, 11.5,
13.5, and 16.5 days post coitum (dpc) and organs were extracted
from adult females. Tissues were disrupted in Trizol (GibcoBRL) by
using a dounce homogenizer, and RNA was extracted according to
the manufacturer’s protocol. RNA was then used for reverse
transcription followed by PCR using the ThermoScript RT-PCR
system according to manufacturer’s instructions (Life Technolo-
gies). First-strand cDNA was synthesized by using random primers,
and PCR was performed on the resulting cDNA template by using
N-twist-specific primers (5-GGCCGCCTATCCAGAGAGC-3
and 5-AAGGAAATGTAGACGATGGC-3). GAPDH primers (5-
TTCCAGTATGACTCCACTCA-3 and 5-ATCACGCCACAGC-
TTTCCAG-3) were used for cDNA amplification as a positive
control.
Electrophoretic Mobility Shift Assay
N-twist cDNA was cloned into pCDNA1/amp (Invitrogen), and
E12 was cloned into pCITE-2A (Novagen) (Molkentin et al., 1995)
for use in in vitro transcription reactions. N-twist and E12 were
cotranscribed with T7 polymerase and cotranslated in vitro by
using the TNT Quick Coupled Transcription/Translation System
as described in manufacturer’s directions (Promega). DNA-binding
reactions were performed as described (Gossett et al., 1989). A total
of 2 g of double-stranded oligonucleotide representing the muscle
creatine kinase (MCK) Right E box (Amacher et al., 1993) were
labeled with 32P-dCTP and purified on a nondenaturing
polyacrylamide–TBE gel. Then, 1 g of poly(dI-dC) 2 l of N-Twist/
E12, and competitor DNA were preincubated at room temperature
in 1 binding buffer (40 mM KCl, 15 mM Hepes, pH 7.9, 1 mM
EDTA, 0.5 mM DTT, 5% glycerol) for 10 min prior to probe
addition. The reaction was incubated an additional 20 min at room
temperature after probe addition and electrophoresed on a 6%
nondenaturing polyacrylamide gel. A 50-fold excess of unlabeled
MCK Right E box (Amacher et al., 1993) or HRC E-box (B.L.B.,
unpublished observations) was used as strong and weak competitor
E boxes, respectively. A mutant MCK right E box (mut) that does
not bind bHLH heterodimers was also used at a 50-fold excess as a
competitor in these assays (Amacher et al., 1993).
In Situ Hybridization
Mouse. Wild-type mouse embryos were collected at 9.5, 11.5,
and 13.5 dpc. Brains were removed from adult females. A Leica RM
2155 microtome was used to cut 5-m transverse and parasagittal
sections as described previously (Wilkinson and Nieto, 1993).
Digoxigenin (DIG)-labeled antisense RNA probe was added to the
slides at a concentration of 1 g/ml and hybridized, washed, and
developed using BM purple AP substrate (Roche Molecular Bio-
chemicals) as described (Wilkinson and Nieto, 1993). DIG-labeled
N-twist antisense RNA probe was synthesized with T7 polymerase
from plasmid pBluescript/N-twist (linearized with SpeI) by using
the digoxigenin RNA labeling kit from Roche Molecular Biochemi-
cals. For sense control probe, plasmid pBluescript/N-twist was
linearized with XhoI, and transcripts were generated by using T3
RNA polymerase. DIG-labeled Mash1 antisense probe was made
using SP6 polymerase with XbaI-linearized template PGEM7Zf-
MASH1 (kindly provided by J. Rubenstein). DIG-labeled neuroge-
nin2 antisense probe was made by using T7 polymerase and
pGEM3-ngn2 (kindly provided by J. Rubenstein) linearized with
BamHI.
Fly. To make an antisense Drosophila N-twist probe, the
plasmid pBluescript SK()/CG6913 (Research Genetics), was lin-
earized with EcoRI and transcripts were generated by using T7
RNA polymerase and DIG-labeled UTP (Roche Molecular Bio-
chemicals, Indianapolis, IN). To make a control sense probe, the
plasmid was linearized with XhoI and transcripts were generated by
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using T3 RNA polymerase (Roche). To generate an antisense
wingless probe, the plasmid pSKII/wg was linearized with BamHI
and transcripts were generated by using T7 RNA polymerase and
biotin-labeled UTP (Roche). To make an antisense engrailed probe,
the plasmid pKSII/en was linearized with EcoRV and transcripts
generated using T7 RNA polymerase and biotin-labeled UTP.
Single-stain and double-stain in situ hybridization to 0–16 h
wild-type embryos was carried out essentially as described by
O’Neill and Bier (1994). Following hybridization and incubation
with anti-DIG antibody (N-twist) or anti-biotin antibody (wingless
and engrailed) (Roche), signal was detected by using either alkaline
phosphatase BCIP/NBT (N-twist) substrate or the Vectastain Elite
staining kit (wingless and engrailed; Vector Laboratories, Burlin-
game, CA). Stained embryos were cleared and mounted in 80%
(v/v) glycerol for photography.
Expression Plasmids, Transfections, and CAT
Assays
The expression plasmid GAL4(DBD), also called pSG424, en-
codes the DNA-binding domain of GAL4 (amino acids 1–147) under
control of the SV40 promoter (Sadowski and Ptashne, 1989). The
plasmids GAL4(DBD)-N-Twist, GAL4(DBD)-E12 (Molkentin et al.,
1995), GAL4(DBD)-MASH1 (Black et al., 1996), and GAL4(DBD)-
MyoD encode the N-Twist bHLH (amino acids 98–166), the E12
bHLH, the MASH1 bHLH, and the MyoD bHLH fused downstream
of the GAL4 DBD in plasmid GAL4(DBD), respectively. The
primers used to generate the MyoD bHLH region have been
described previously (Black et al., 1998). Plasmid E12-VP16 en-
codes a portion of the E12 cDNA sequence, including the bHLH
domain, from the E2-5 gene fused to the herpesvirus virion protein
16 (VP16) activation domain under control of the SV40 promoter
(Black et al., 1998). The chloramphenicol acetlytransferase (CAT)
reporter plasmid, PG5E1bCAT, contains five copies of the yeast
GAL4 DNA-binding site upstream of the adenovirus E1b minimal
promoter driving expression of CAT (Lillie and Green, 1988). The
CAT reporter plasmid, 4R-tk-CAT contains four copies of the
muscle creatine kinase (MCK) Right E box upstream of the
thymidine kinase (TK) minimal promoter directing expression of
CAT (Weintraub et al., 1990). The E12 expression vector, EMSV-
E12, encodes a partial E12 cDNA, referred to as E12R, under control
of the EMSV long terminal repeat (LTR) (Murre et al., 1989). The
MASH1 expression plasmid, RSV-MASH1, encodes the rat MASH1
cDNA under control of the RSV LTR (Johnson et al., 1992; Black et
al., 1996). The expression plasmid for N-Twist, SV2.N-Twist
encodes the full-length human N-twist cDNA under control of the
SV40 promoter.
C3H10T1/2 (10T1/2) cells were maintained in Dulbecco’s Modified
Eagle Medium (DMEM) supplemented with 10% fetal calf serum
(FCS). Transfections were performed by calcium phosphate precipita-
tion as described elsewhere (Black et al., 1995). In each transfection,
10 g (unless otherwise indicated) of total plasmid DNA was trans-
fected by mixing it with 0.187 ml of 0.25 M CaCl2 and 0.187 ml of 2
BBS (50 mM BES, 250 mM NaCl, 1.5 mM Na2HPO4, pH 6.95) and
adding this mixture to the cells. In samples where an expression
plasmid was not transfected, an equal amount of the parental expres-
sion vector was transfected. Our previous studies have demonstrated
approximately equivalent levels of expression from the EMSV, RSV,
and SV40 promoters used in these studies (Black et al., 1996).
Transfected cells were harvested, and cellular extracts were prepared
by sonication as described previously (Black and Lyles, 1992). Trans-
fected cell lysates were normalized (Lowry et al., 1951), and an
equivalent amount of cell lysate from each transfection was assayed
for chloramphenicol acetyltransferase (CAT) activity as described
elsewhere (Black and Lyles, 1992). Reactions were conducted for 5 h at
37°C. Conversion to acetylated forms was analyzed by thin-layer
chromatography and quantitated by PhosphorImager (Molecular Dy-
namics) analysis.
RESULTS
N-Twist Is a Novel bHLH Transcription Factor
A database search for bHLH genes identified N-twist, a
novel gene with close homology to other members of the
bHLH family, in the human genome. The human genome
sequence revealed that N-twist is closely linked to M-twist
at 7p15 (GenBank Accession No. AC003986). The two
genes are separated by only 27,300 bp. The high homology
and close physical linkage to M-twist suggests this novel
bHLH gene may have evolved from a duplication of a
common ancestor with M-twist. Because this novel gene is
expressed in neuronal tissues (See Figs. 2 and 3), and
because of its close physical linkage and high degree of
sequence similarity to M-twist (Fig. 1C), we have named
this novel bHLH gene Neuronal-twist (N-twist). N-twist is
a single exon gene predicted to encode a protein of 166-
amino-acid residues (Fig. 1A). Mouse and human N-twist
are highly conserved throughout the entire coding region
and show complete amino acid conservation in the bHLH
domain (Fig. 1B). N-twist is highly conserved across species
(Fig. 1B), suggesting that this gene product has an evolu-
tionarily conserved function. Southern blot analyses on
mouse and human genomic DNA using an N-twist-specific
probe, combined with a database search, indicated that
N-twist is a unique gene in both the murine and human
genomes (data not shown). The N-Twist bHLH has a high
degree of similarity to other bHLH proteins at the amino
acid level and is most closely related to p48/PTF-1,
Dermo-1, and M-Twist (Fig. 1C).
N-twist Is Expressed in the Developing and Adult
Mouse Central Nervous System
To determine the temporal pattern of N-twist expression
during mouse embryogenesis, we performed RT-PCR anal-
yses on RNA isolated from mouse embryos between 7.5 and
16.5 dpc. These analyses identified N-twist expression in
mouse embryos as early as 8.5 dpc, but expression was more
robust at 9.5 dpc (data not shown). RT-PCR analyses also
detected N-twist expression in neural tissues at 11.5, 13.5,
and 16.5 dpc, as well as in some regions of the adult brain
(data not shown). To better characterize the N-twist expres-
sion pattern, in situ hybridization analyses were performed
by using a probe to detect N-twist transcripts on parasagit-
tal and transverse sections derived from mouse embryos at
9.5, 11.5, and 13.5 dpc, and in sections of the adult brain
(Fig. 2). Between 9.5 and 13.5 dpc, N-twist expression was
detected only in the ventral neural tube. Expression ap-
peared to be primarily in progenitor cells. At 9.5 dpc,
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N-twist RNA was detected in the ventral midline and
paramedial parts of the caudal diencephalon and mesen-
cephalon. Expression was also detected in the ventral spinal
cord (Figs. 2A and 2E). N-twist expression was also seen
more caudally in the midbrain on adjacent sections (data
not shown). At 11.5 dpc, N-twist expression in the ventral
mesencephalon showed a caudal to rostral gradient (Fig. 2B),
and expression was restricted to the midline (Fig. 2F). By
13.5 dpc, N-twist expression appeared to be down-regulated
in the diencephalon and mesencephalon, but was promi-
nent in the rostral rhombencephalon (pons) (Fig. 2C). Ex-
pression in the midbrain at 13.5 dpc was further restricted
FIG. 1. N-twist sequence is highly conserved across species and is closely related to other members of the bHLH family of transcription
factors. (A) The full-length murine cDNA sequence of N-twist and the predicted 166-amino-acid sequence. The bHLH domain is
underlined. The asterisk represents the stop codon. (B) bHLH domain amino acid sequence comparison shows N-Twist is highly conserved
across species. (C) N-Twist is closely related to other members of the bHLH family; percent similarity is indicated. Identical amino acids
are represented in white text; similar amino acids are represented in yellow text.
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FIG. 2. N-twist mRNA is expressed in the developing mouse central nervous system. Parasagittal (A–D) and transverse (E–I) sections of
mouse embryos or adult brain (D) were hybridized to antisense N-twist probe (A–G), antisense neurogenin2 probe (H), or antisense Mash1
probe (I). In 9.5-dpc embryos, N-twist transcript was detected at the midline of the developing caudal diencephalon and mesencephalon in
the midbrain region and in the ventral neural tube (A, E). At 11.5 dpc, N-twist RNA was detected in the ventral mesencephalon at the
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to the ventral midline at the floor plate (Fig. 2G). N-twist
transcripts were also detected more caudally at 13.5 dpc in
the ventral neural tube at the midline (Fig. 2C). Expression
of N-twist in the adult mouse was restricted to a small
region at the midline of the brain at the inferior border of
the posterior commissure between the thalamus and the
superior colliculus (Fig. 2D).
To more carefully define the cells in the ventral neural
tube expressing N-twist, we compared the expression of
N-twist with other well-characterized bHLH transcription
factors on adjacent transverse sections at 13.5 dpc (Fig. 2).
Expression of N-twist (Fig. 2G) overlapped with the expres-
sion of neurogenin2 (Fig. 2H) and Mash1 (Fig. 2I) in the
ventral midbrain. N-twist was expressed at a comparable
level to MASH1 in the ventral neural tube at this stage, and
its overlap with neurogenin2 supports the notion that
N-twist is expressed in a subpopulation of neural progenitor
cells (Sommer et al., 1996; Simmons et al., 2001).
Expression of N-twist in Drosophila Is also
Restricted to the Nervous System
The highly conserved sequence of the N-twist bHLH
domain (Fig. 1B) suggests that the function of this gene may
be conserved between invertebrates and vertebrates. To
determine whether the neural expression pattern of N-twist
was also conserved, we examined the embryonic expression
pattern of N-twist in Drosophila. Transcripts of N-twist
were completely restricted to the developing central ner-
vous system (Fig. 3). N-twist expression was first detected
at early stage 11 in single clusters of cells per hemisegment
in the neurogenic ectoderm (Fig. 3A). These clusters ap-
peared rapidly in an anterior to posterior manner and each
cluster consisted of 2 to 4 cells. By late stage 11 (Fig. 3B), 13
large clusters of cells were detected expressing N-twist
(designated lc1–lc13) and 13 smaller clusters had also arisen
slightly anterior to the larger clusters (designated sc1–sc13).
The number of cells in each large cluster had increased to
4–8 cells, and the smaller clusters comprised 1–2 cells.
Expression of N-twist persisted through germ band short-
ening (Fig. 3C), and at stage 13, strong expression was still
detected in the large and small cell clusters (Fig. 3D). The
number of cells in each cluster remained largely unchanged
between stages 11 and 13. As a result of the shortening of
the germ band, the closely apposed large and small clusters
had moved closer together and were sometimes difficult to
distinguish at this and subsequent stages (Fig. 3E).
Several additional groups of cells were also detected
expressing N-twist at stage 13 (Fig. 3D). Two paired clusters
of cells were detected in the developing ventral nerve cord
of the embryo. One group of approximately 2 cells was
located anterior to lc1, and one group of approximately 2
cells was located posterior to lc13. In addition, 3 pairs of cell
clusters in the procephalic region of the embryo also ex-
pressed N-twist. A dorsal view of a stage 13 embryo (Fig. 3F)
demonstrated that some of these cells in the procephalic
region were located at the anterior tip of the brain lobes.
Following dorsal closure, the posterior two clusters of cells
failed to express N-twist at high levels such that expression
posterior to lc12 was rarely detectable (Fig. 3G). However,
the anterior clusters of cells continued to express N-twist at
stage 13. The procephalic expression persisted, and at stage
14, N-twist was expressed in approximately 20 cells in each
brain lobe, such that initially distinct clusters of cells were
indistinguishable. At later stages of development, N-twist
expression was still detectable in the brain and ventral
nerve cord, although at reduced levels and in a more limited
number of cells (Fig. 3H).
To more precisely define the location of N-twist-
expressing cells in the Drosophila embryo relative to other
domains of gene expression, and to begin identifying sub-
sets of neuroblasts with which N-twist cells might corre-
spond, we performed double-stained in situ hybridization
using an N-twist probe and probes to either engrailed or
wingless (Figs. 3J and 3K). We found that engrailed expres-
sion precisely overlapped with the location of the large
clusters of cells (Fig. 3J), while the small clusters of cells
overlapped with the expression pattern of wingless in the
ventral region of the embryo (Fig. 3K). These findings
indicate that the large clusters of cells likely correspond to
a subset of the neuroblasts from rows 6 or 7, while the small
clusters of cells probably correspond to some of the neuro-
blasts from row 5 (Doe, 1992; Goodman and Doe, 1993).
Taken together, the data presented in Figs. 2 and 3 demon-
strate that mouse and Drosophila N-twist each have highly
restricted patterns of expression in a subset of cells in the
CNS, further suggesting a conserved function for N-Twist
during development in vertebrates and invertebrates.
N-Twist Forms a Heterodimer with E Protein and
Binds the E Box Motif
One hallmark of tissue-restricted bHLH transcription
factors (class B) is the ability to heterodimerize with class A
midline and in the developing rhombencephalon/pons (B, F). By 13.5 dpc, N-twist was expressed more caudally than at 11.5 dpc into the
hindbrain region (C). Expression in the brain at 13.5 dpc was largely restricted to the pons at the floor plate (G). Expression in the ventral
neural tube at 13.5 dpc was restricted to the midline (C, G). In the adult mouse brain, N-twist was expressed in a restricted area at the
inferior border of the posterior commissure (D). Expression of N-twist overlapped with the expression of neurogenin2 and Mash1 at 13.5
dpc (G–I). Arrows indicate sites of N-twist expression. Asterisks indicate sites of overlapping expression with neurogenin2 (ngn2) and
Mash1. Abbreviations: fp, floor plate; mb, midbrain; mv, mesencephalic vesicle; nt, neural tube; pc, posterior commissure; sc, superior
colliculus; T, thalamus; TV, telencephalic vesicle; V4, fourth ventricle. Bar, 100 m, unless otherwise indicated.
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bHLH proteins of the E2A family and for those het-
erodimers to bind to a DNA sequence known as an E box.
To determine whether N-twist could bind to the E box
motif in vitro, we used electrophoretic mobility shift assays
(EMSA) to test whether N-Twist could bind to the canoni-
cal bHLH binding site from the muscle creatine kinase
(MCK) enhancer. N-Twist bound specifically to the E box
sequence (Fig. 4). This binding occurred only in the pres-
ence of cotranslated E12 (lanes 2 and 5). In the absence of
E12, no DNA binding by N-Twist was observed (lane 6),
indicating that N-Twist does not bind DNA as a ho-
modimer or monomer. N-Twist binding to the E box was
specific as it was efficiently competed by an excess of
unlabeled canonical MCK Right E box (lane 3). Binding was
also competed less efficiently by an E box with a slightly
weaker affinity for bHLH binding (lane 4). Binding of
N-Twist to the MCK Right E box was not competed by a
50-fold excess of an unlabeled mutant Right E box incapable
of bHLH binding (Amacher et al., 1993) (lane 5). These
results suggest that N-Twist, like many class B bHLH
proteins, binds DNA as a heterodimer with class A bHLH
proteins such as E12 and E47.
To determine whether N-Twist could dimerize with E
protein in vivo, we performed a mammalian cell two-hybrid
experiment in 10T1/2 cells (diagrammed in Fig. 5A). The
N-Twist bHLH domain was fused to the GAL4 DNA-
binding domain (DBD) to determine whether N-Twist
could dimerize with the bHLH domain of E12. The bHLH
domain of E12 was expressed as a herpesvirus virion protein
16 (VP16) fusion protein such that dimerization of N-Twist
with the E protein bHLH domain would recruit the potent
VP16 activation domain to the adenovirus E1b minimal
promoter present in the GAL4-dependent chloramphenicol
acetyltransferase (CAT) reporter plasmid, pG5E1b-CAT
(Fig. 5B). N-Twist dimerization with E12-VP16 (lane 6)
resulted in CAT activity which was threefold higher than
that which occurred upon E12-VP16 dimerization with the
positive control, MyoD (lane 5). The activation of the
reporter observed in this experiment was due to the pres-
ence of the bHLH domains of MyoD and N-Twist since the
GAL4(DBD) plasmid, pSG424, without a fused bHLH do-
main showed no significant activation when coexpressed
with E12-VP16 (lane 4). The potent activation of the re-
porter by N-Twist and E12-VP16 suggests that N-Twist is a
strong dimerization partner for E protein in vivo.
N-Twist Functions as an Inhibitor of Transcription
Since N-Twist appeared to have the DNA binding and
dimerization properties of a typical class B bHLH protein,
we tested whether N-Twist could act as a transcriptional
activator. cDNAs encoding full-length N-Twist, and three
truncation mutants of the N-Twist protein (amino acids
1–166, 98–166, 1–98, and 36–98) were fused to the GAL4
DBD cDNA and were assayed for their ability to activate
transcription from the GAL4-dependent reporter construct,
pG5E1b-CAT, in 10T1/2 cells. No significant transcrip-
tional activation by any of the N-Twist/GAL4 fusions was
detected, indicating that N-Twist lacks a transcriptional
activation domain (data not shown). In these experiments,
the well-studied bHLH activators, MASH1 and MyoD, each
robustly activated transcription (greater than 20-fold acti-
vation), and no effect of coexpression of E12 was observed
on the activation potential of N-Twist, MASH1, or MyoD
(data not shown).
The absence of an activation domain, combined with
N-twist’s linkage and homology to M-twist suggested that
N-Twist, like M-twist, might function as a transcriptional
inhibitor. To test the possibility that N-Twist functions as
a transcriptional inhibitor, the effect of N-Twist on the
ability of mammalian achaete-scute homolog-1 (MASH1), a
class B neurogenic bHLH activator (Johnson et al., 1990), to
activate transcription of the E box-dependent reporter plas-
mid, 4R-tk-CAT, was determined. MASH1 was selected as
a representative neurogenic bHLH gene for this experiment
because its temporospatial expression pattern during devel-
opment overlaps in part with the N-twist expression pat-
tern (Fig. 2; Guillemot and Joyner, 1993; Ma et al., 1997;
Verma-Kurvari et al., 1998; Meredith et al., 2000). Further-
more, MASH1 provided a well-studied example of a neuro-
genic activator to investigate how N-Twist might function
during neurogenesis (Guillemot and Joyner, 1993; Guil-
lemot, 1995, 1999). 10T1/2 cells were transfected with the
E box-dependent CAT reporter, along with expression plas-
mids encoding E12, and either MASH1, N-Twist, or
MASH1 and N-Twist together (Fig. 6A). MASH1 and E12
strongly activated the reporter plasmid via the MASH1
activation domain (lane 4). However, when N-Twist expres-
sion plasmid was cotransfected with MASH1 and E12, CAT
reporter levels were four-fold lower than with MASH1/E12
in the absence of N-Twist (lane 5). This result demonstrates
that N-Twist can function as a transcriptional inhibitor of
the neurogenic bHLH protein MASH1. This inhibition of
MASH1-dependent activation of the E box reporter plasmid
by N-Twist (Fig. 6A) could occur by two potential mecha-
nisms which are depicted in Fig. 6B: (1) by competing for
DNA binding at the E box; or (2) by inhibiting dimerization
of MASH1 with its E protein partner.
N-Twist’s Inhibitory Activity Is Mediated by
Sequestering E Protein
To test whether N-Twist could compete for DNA binding
at the E box, competitive EMSAs were performed. In these
assays, both MASH1/E12 and N-Twist/E12 were incubated
together with a limiting amount of radiolabeled E box
DNA. N-Twist did not prevent MASH1/E12 from binding
DNA in this assay (data not shown). In fact, the MASH1/
E12 heterodimer showed a slightly higher affinity for E box
binding than the N-Twist/E12 heterodimer (data not
shown). This suggested that saturation of DNA binding
sites is unlikely to be the primary mechanism by which
N-Twist inhibited MASH1 trans-activation in the experi-
ment shown in Fig. 6A.
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FIG. 3. Expression of N-twist during Drosophila embryogenesis. (A) At early stage 11, expression was weak in the developing ventral nerve
cord and appeared first in cells destined to give rise to “large clusters” of N-twist-expressing cells (lc1). More anterior cells showed the
strongest initial staining. (B) At late stage 11, one large cluster (lc) and one small cluster (sc) of N-twist-positive cells was detectable in each
of 13 hemisegments. Expression in these clusters persisted through stage 12 (C) and stage 13 (D). Additional staining was detected at this
stage in one anterior (an) and posterior (po) paired group of cells in the ventral region, as well as in three paired groups of cells in the
procephalic region (pc). (E) A ventral view of a stage 13 embryo demonstrating the close apposition of the large and small clusters of cells
that resulted from germ band shortening (the third cluster is denoted as an example). (F) Dorsal view of a stage 13 embryo demonstrating
that the procephalic expression of N-twist was localized to the anterior portion of the brain lobes (br) on each side of the animal. (G) Stage
14 embryos showed persistent N-twist expression clearly detectable in the ventral nerve cord (vnc) and the procephalic region. The posterior
cluster (po) and lc13 showed no detectable expression. This level and pattern of expression was maintained through stages 15 (not shown)
and 16 (H). (I) Sense probe showed no hybridization at any stage (stage 14 is shown as an example). (J) Expression of engrailed (brown) and
N-twist (purple) viewed from the ventral side of a stage 12 embryo. Note that the engrailed stripe overlaps exactly with the location of the
large clusters of N-twist-expressing cells. (K) Expression of wingless (brown) and N-twist (purple) in a ventrolateral view of a stage 12
embryo. Note that the wingless stripe overlaps exactly with the location of the small clusters of N-twist-expressing cells and not the large
clusters. All panels are lateral views with anterior to the left and dorsal side up, unless otherwise indicated. Bar, 100 m.
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To test the possibility that N-Twist inhibited MASH1
trans-activation by sequestering E protein, we tested the
ability of a GAL4-MASH1 fusion protein to recruit E12-
VP16 to a GAL4-dependent reporter plasmid in the presence
or absence of N-Twist (schematized in Fig. 7A). In the
absence of N-Twist, MASH1 dimerized with E12-VP16,
resulting in potent activation of the GAL4-dependent re-
porter plasmid, pG5E1b-CAT (Fig. 7B, lane 5). In dramatic
contrast, coexpression of an equal amount of N-Twist
expression plasmid nearly abolished this activity (Fig. 7B,
lane 6). This experiment suggests that the mechanism of
N-Twist inhibition of MASH1-dependent transcriptional
activation is due to sequestration of its E protein het-
erodimerization partner. Alternatively, N-Twist could be
inhibiting activation in this assay by dimerizing with
MASH1. To determine whether N-Twist might function
through direct dimerization with MASH1, we performed a
mammalian two-hybrid assay using N-Twist as bait. In this
assay, N-Twist efficiently dimerized with E12, but was
completely incapable of dimerization with MASH1 (data
not shown).
To further examine the inhibition of MASH1-E12 dimer-
ization by N-Twist, we performed a titration of N-Twist to
MASH1 in a mammalian two-hybrid assay using E12 as bait
(depicted in Fig. 8A). In this assay, the GAL4(DBD)-E12 bait
efficiently recruited MASH1 and this dimerization led to a
FIG. 4. N-Twist/E12 heterodimers efficiently bind the E box sequence. N-Twist and E12 were cotranscribed and cotranslated in vitro and
incubated with a radiolabeled MCK Right E box (Amacher et al., 1993) for EMSA. N-Twist/E12 heterodimers retarded the mobility of the
E box (lane 2). This binding was specific as it was competed by excess unlabeled E box (lanes 3 and 4) but not by an unlabeled mutant E
box (lane 5). N-Twist did not bind DNA as a monomer or homodimer (lanes 6 and 7) while E12 homodimers had weak, but specific, binding
activity (lanes 8 and 9). Lane 1 contains unprogrammed cell lysate (lysate-derived mobility shifts are noted). The mck competitor (lanes 3,
7, and 9) represents a strong, canonical E box. The hrc competitor (lane 4) represents a consensus, but relatively weaker, E box. The mutant
(mut) competitor (lane 5) is a mutant MCK Right E box incapable of bHLH protein binding (Amacher et al., 1993). Plus and minus signs
represents the presence or absence of in vitro translated E12 or N-Twist, respectively. In samples where an in vitro translated protein is
absent (minus sign), an equal amount of unprogrammed lysate is included.
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FIG. 5. N-Twist dimerizes with E protein in vivo. (A) Schematic representation of the mammalian cell two-hybrid assay used in this
experiment. The GAL4 DNA-binding domain was fused to the bHLH domain of either N-Twist or MyoD, and this fusion was used as “bait”
to determine whether an E12 bHLH-VP16 fusion protein “prey” could dimerize with N-Twist via their HLH domains. If dimerization
occurs in this assay, the VP16 activation domain is recruited to the adenovirus E1b minimal promoter resulting in an increase in CAT
reporter gene activity. (B) 10T1/2 cells were transfected with the GAL4-dependent CAT reporter plasmid, pG5E1bCAT, and the indicated
fusion proteins. GAL4(DBD)-N-Twist plus E12-VP16 (lane 6) resulted in threefold higher CAT activity than GAL4(DBD)-MyoD plus
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potent activation of the CAT-dependent reporter (Fig. 8B,
lane 2). Coexpression of N-Twist completely blocked acti-
vation in this assay (lanes 4–6) even when MASH1 expres-
sion plasmid was present in a four fold excess to N-Twist
expression plasmid (lane 6). N-Twist alone was unable to
activate transcription in this assay (lane 3) due to its lack of
an activation domain. Taken together, the results presented
in Figs. 7 and 8 demonstrate that E12 preferentially dimer-
izes with N-Twist when both N-Twist and MASH1 are
present, even when MASH1 is more abundant than
N-Twist.
DISCUSSION
In this study, we have examined the effect of N-Twist on
MASH1 function as a model to define the function of
N-Twist. The mechanism by which N-Twist inhibited
MASH1 activity in these studies (Fig. 7) appears to be
identical to the mechanism of inhibition mediated by the
HLH protein, Id. Id is expressed in both myogenic and
neurogenic lineages and also functions as a dominant nega-
tive dimerization partner for E protein (Benezra et al., 1990;
Jo¨gi et al., 2002). Other bHLH proteins have also been
shown to function as dominant negative partners for E
proteins, including M-Twist (Spicer et al., 1996; Hebrok et
al., 1997), Capsulin (Lu et al., 1998), and HES1 (Kageyama et
al., 1997). Here we include N-Twist in this functional class
of proteins by showing that N-Twist dimerizes with E
protein with a higher affinity than MASH1 and thus is able
to inhibit MASH1-mediated transcriptional activation in a
dominant negative manner.
Yet while Id/E protein heterodimers do not bind DNA
due to the lack of a basic domain in Id, N-Twist/E protein
heterodimers efficiently bind to the E box sequence (Fig. 4).
The observation that N-Twist can bind strongly to the E
box sequence suggests that it may also have other functions
related to its ability to bind DNA. This notion is consistent
with the multiple inhibitory functions observed for other
bHLH proteins. For example, in addition to their role in
inhibition of dimerization of proneural bHLH proteins with
E proteins, members of the HES family have been shown to
bind DNA and recruit the corepressor Groucho (Paroush et
al., 1994). Likewise, in addition to functioning in a domi-
nant negative fashion by sequestration of E protein from
MyoD, M-Twist also inhibits MyoD function by blocking
the trans-activation potential of the MyoD cofactor MEF2C
(Spicer et al., 1996). Furthermore, Hebrok et al. (1997)
showed that M-Twist could compete for MyoD/E12 binding
to the E box sequence when present in a fourfold excess
over MyoD. In the studies presented here, we did not
observe competition for DNA binding by N-Twist (data not
shown). However, in our studies, N-Twist/E12 were present
at an equimolar ratio with MASH1/E12. Based on the
relatively high affinity of N-Twist/E12 heterodimer for E
box binding, it seems plausible that in cells where N-Twist
is more abundant than MASH1, a similar mechanism may
also apply. It is interesting to note that N-twist expression
also overlaps during development with other proneural
activators such as neurogenin2 (Fig. 2H; Simmons et al.,
2001; Sommer et al., 1996). Based on the ability of N-Twist
to efficiently dimerize with, and sequester E protein, it is
likely that the inhibitory effects of N-Twist on MASH1 also
apply to other neural bHLH activators. Our in situ hybrid-
ization studies (Fig. 2) suggest that Mash1 and N-twist are
expressed at comparable levels in regions of the ventral
neural tube where their expression patterns overlap, and the
results presented in Fig. 8B show that N-Twist potently
inhibits MASH1 dimerization with E protein even at a
fourfold excess of MASH1 plasmid over N-Twist (lane 6).
Taken together, these two observations support the notion
that N-Twist is likely to inhibit MASH1-dependent activa-
tion of gene expression in vivo.
N-twist is closely linked to M-twist at the amino acid
sequence level and physically on chromosome 7p15 in
human. Based on the tight chromosomal linkage and the
high degree of sequence identity (Fig. 1C), it is likely that
these closely related genes are descendants of a common
ancestor. It would be interesting to investigate whether
these two developmental inhibitory genes separated by only
27 kb share common regulatory elements. If so, a different
mechanism for regulation would have evolved in Drosoph-
ila, as the fly orthologs of N-twist and M-twist reside on
different chromosomes. In addition to the sequence identity
and tight physical linkage between N-twist and M-twist in
the mouse, these two bHLH proteins appear to function in
a highly analogous manner as well. M-Twist functions as an
inhibitor of myogenesis by interfering with MyoD function,
and N-Twist may function as an inhibitor of neurogenesis
through its ability to interfere with the function of neural
bHLH activators such as MASH1 (Figs. 6–8).
In genome-wide scans for putative novel bHLH proteins
in Drosophila, two groups have previously reported com-
pletely different patterns of expression for the N-twist gene
in Drosophila. Moore et al. (2000) reported that Fer3 was
expressed in the gut of the developing Drosophila embryo,
while Peyrefitte et al. (2001) showed preliminary evidence
that the gene transcript was expressed in the developing
E12-VP16 (lane 5). Ten g of total plasmid DNA comprising equivalent amounts of each expression plasmid (or parental vector) and reporter
plasmid were transfected in each sample. A minus sign represents the inclusion of an equal amount of the empty E12-VP16 parent vector,
pSV2. pSG424 is the parental GAL4(DBD) plasmid encoding the GAL4 DBD alone. The data shown represent the mean values obtained in
three independent transfections and analyses. Error bars represent the standard error of the mean for each of the sets of three experiments.
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FIG. 6. N-Twist inhibits transcriptional activation of an E box-dependent reporter by MASH1/E12. (A) MASH1 and E12 activate
transcription of the E box-dependent reporter (lane 4), but the presence of N-Twist blocks this trans-activation (lane 5). E12 alone and
N-Twist/E12 (lanes 2 and 3) have little activity above vector control (lane 1). Ten g of total plasmid DNA were transfected in each sample:
2 g each of the reporter plasmid and expression plasmids for E12 and MASH1 and 4 g of N-Twist expression plasmid. A minus sign
represents the inclusion of an equal amount of empty parent vector for MASH1, N-Twist, or E12. The data shown represent the mean values
obtained in three independent transfections and analyses. Error bars represent the standard error of the mean for each of the sets of three
experiments. (B) Possible mechanisms for N-Twist’s inhibition of MASH1-dependent trans-activation: competition for DNA binding at the
E box or by inhibition of dimerization of MASH1 with its E protein partner.
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FIG. 7. N-Twist disrupts MASH1/E protein dimerization. (A) Schematic representation of the dimerization assay performed in this experiment.
The MASH1 bHLH was fused to the GAL4 DNA-binding domain to assay dimerization with an E12 bHLH-VP16 fusion and recruit recruitment
of VP16 to the GAL4-dependent reporter construct. (B) 10T1/2 cells were cotransfected with the GAL4-dependent CAT reporter plasmid,
pG5E1bCAT, and the indicated fusion proteins. GAL4(DBD)-MASH1 dimerization with E12-VP16 resulted in high levels of reporter gene activity
(lane 5). Coexpression of N-Twist inhibited trans-activation by the GAL4-MASH1 bHLH fusion and E12-VP16, presumably by blocking
dimerization (lane 6). Ten g of total plasmid DNA were transfected in each sample: 2 g of reporter plasmid, 2 g E12-VP16 plasmid, 2 g
GAL4(DBD) plasmid, and 4 g N-Twist expression plasmid. A minus sign represents the inclusion of an equal amount of empty parent vector
for N-Twist, or E12-VP16. pSG424 is the parental GAL4(DBD) plasmid encoding the GAL4 DBD alone. The data shown represent the mean
values obtained in five independent transfections and analyses. Error bars represent the standard error of the mean for each of the sets of five
experiments.
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FIG. 8. N-Twist efficiently competes with MASH1 for E12 dimerization. (A) Schematic representation of the dimerization and titration
assay performed in this experiment. The E12 bHLH domain was fused to the GAL4 DNA-binding domain to determine the relative ability
of N-Twist to compete for MASH1 dimerization with E12 by assaying activation of a GAL4-dependent reporter plasmid. (B) 10T1/2 cells
were cotransfected with the GAL4-dependent CAT reporter plasmid, pG5E1bCAT, and the indicated expression plasmids. GAL4(DBD)-E12
dimerization with MASH1 resulted in high levels of reporter gene activity due to the potent endogenous activation domain present in
MASH1 (lane 2). Coexpression of N-Twist inhibited trans-activation by the GAL4-E12 bHLH fusion and MASH1 by blocking dimerization
(lanes 4–6). N-Twist expression plasmid was expressed at varying ratios to MASH1 expression plasmid (2:1, lane 4; 1:2, lane 5; and 1:4, lane
6). Fifteen g of total plasmid DNA were transfected in each sample: 2 g of reporter plasmid, 1 g GAL4(DBD)-E12, 4 g MASH1
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central nervous system. Therefore, we performed a detailed
analysis of the expression of this gene to clarify and further
define the expression pattern of N-twist in the Drosophila
embryo, and to extend previous observations of its distri-
bution during development. Our findings were in general
agreement with those of Peyrefitte et al. (2001). N-twist
expression in Drosophila was completely restricted to the
developing CNS, while no expression in the midgut was
observed (Fig. 3). Likewise, Segev et al. (2001) made an
initial characterization of murine N-twist, calling it Nato3
based on its homology to Atonal. These previous studies
made an initial, preliminary characterization of the expres-
sion of N-twist by nonlinear RT-PCR analysis of embryonic
and adult tissues (Segev et al., 2001). We have extended
these analyses of N-twist expression in the vertebrate
system with detailed analyses of expression in the develop-
ing mouse by in situ hybridization (Fig. 2) and by perform-
ing functional studies on N-Twist’s DNA binding (Fig. 4),
dimerization (Fig. 5) and potential mechanism of action
(Figs. 6–8). Our results indicate that N-twist is expressed
primarily in the ventral neural tube (Fig. 2). By 13.5 dpc, the
expression of N-twist overlaps with the expression of
Mash1 and neurogenin2 in regions of the rostral neural tube
(Figs. 2H and 2I). The overlapping expression with neuro-
genin2 (Fig. 2H) supports the notion that N-twist is ex-
pressed in neural progenitor cells in the ventral neural tube.
We have shown further that N-Twist inhibits MASH1-
dependent transcriptional activation by sequestration of
MASH1’s heterodimerization partner E12 (Figs. 7 and 8).
Based on our detailed analysis of the physical linkage,
sequence identity, and functional parallels with M-Twist,
we propose the name N-twist for this neural bHLH
inhibitor.
Based on the timing of N-twist expression in both the fly
and mouse, it is unlikely that N-Twist plays a role in
regulating neural specification, but it may be involved in
neural differentiation. Since early neural specification first
commences around stage 9 in the fly (Campos-Ortega,
1993), the lack of N-twist expression during this time
indicates that it likely does not function in the initial
demarcation of early proneural clusters in the embryo.
Although N-twist may function in the formation of later
proneural clusters, this seems unlikely since N-twist is
expressed in neuroblasts located inside the ectoderm (Fig.
3).
Temporal expression in the mouse is consistent with
what we observed in Drosophila. In the mouse, neural
specification genes are first expressed at 8.5 dpc, whereas
N-twist expression is not detected strongly until 9.5 dpc.
Again, as in the fly, N-twist may be preventing terminal
differentiation in cells in which it is expressed. It would be
interesting to investigate whether N-twist expressing cells
have exited the cell cycle, or are still dividing. We did
observe an increase in the number of N-twist expressing
cells from stages 11 through 13 in Drosophila (Fig. 3). While
this may represent recruitment of additional cells to a
particular phenotype, it is more likely that this simply
represents proliferation of N-twist expressing neuroblasts
during this time. The timing of the increase in cell number
also correlates with periods of neuroblast proliferation
(Campos-Ortega, 1993).
The expression of N-twist in the developing mouse be-
comes increasingly restricted to the midline as develop-
ment proceeds from 9.5 to 13.5 dpc. Such reduction in
expression is also seen in Drosophila from stage 13 to stage
16. The reduction in N-twist transcript over these develop-
mental stages coincides with the onset of neural differen-
tiation. In this regard, N-Twist may be acting as an inhib-
itor of differentiation, maintaining cells in the neuroblast
state, until later in development when a specific neural
subtype will be produced. Future studies will provide in-
sight into how N-Twist functions in the developing central
nervous system.
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